May 01, 2025 9:30am EDT 180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
Dec 27, 2024 9:00am EST 180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
Dec 12, 2024 8:00am EST 180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
Dec 04, 2024 8:00am EST 180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
Oct 31, 2024 8:00am EDT 180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
Oct 16, 2024 8:00am EDT 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
Oct 09, 2024 8:30am EDT 180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector